Mosunetuzumab/Polatuzumab Vedotin Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of mosunetuzumab and polatuzumab vedotin that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL).

**Synonyms:** - Lunsumio/Polivy Regimen - Mosunetuzumab Plus Polatuzumab Vedotin - Mosunetuzumab Plus Polatuzumab Vedotin-piiq - Mosunetuzumab-Polatuzumab Vedotin - Mosunetuzumab-axgb/Polatuzumab Vedotin-piiq - Mosunetuzumab/Polatuzumab Vedotin - Polatuzumab Vedotin-piiq/Mosunetuzumab-axgb - Polatuzumab Vedotin/Mosunetuzumab - Polivy/Lunsumio